391 related articles for article (PubMed ID: 25174822)
21. Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia.
Lönnerholm G; Valsecchi MG; De Lorenzo P; Schrappe M; Hovi L; Campbell M; Mann G; Janka-Schaub G; Li CK; Stary J; Hann I; Pieters R;
Pediatr Blood Cancer; 2009 May; 52(5):596-601. PubMed ID: 19132729
[TBL] [Abstract][Full Text] [Related]
22. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of neutrophil gelatinase-associated lipocalin, interleukin-18, and cystatin C as molecular markers before and after unilateral shock wave lithotripsy.
Kardakos IS; Volanis DI; Kalikaki A; Tzortzis VP; Serafetinides EN; Melekos MD; Delakas DS
Urology; 2014 Oct; 84(4):783-8. PubMed ID: 25135871
[TBL] [Abstract][Full Text] [Related]
24. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
[TBL] [Abstract][Full Text] [Related]
25. Solitary serum methotrexate level 36 hours post high-dose methotrexate: A safe, efficacious, and cost-effective strategy to monitor methotrexate toxicities in childhood leukemia in resource-limited centers.
Khera S; Kapoor R; Pramanik SK
Pediatr Blood Cancer; 2020 Jul; 67(7):e28387. PubMed ID: 32400952
[TBL] [Abstract][Full Text] [Related]
26. Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial.
Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Cardinal JW; Coombes JS
Nephrol Dial Transplant; 2012 Jan; 27(1):182-9. PubMed ID: 21543653
[TBL] [Abstract][Full Text] [Related]
27. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
[TBL] [Abstract][Full Text] [Related]
28. Urinary cystatin C and NGAL as early biomarkers for assessment of renal ischemia-reperfusion injury: a serum marker to replace creatinine?
Woodson BW; Wang L; Mandava S; Lee BR
J Endourol; 2013 Dec; 27(12):1510-5. PubMed ID: 24266750
[TBL] [Abstract][Full Text] [Related]
29. Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children.
Madsen MG; Nørregaard R; Palmfeldt J; Olsen LH; Frøkiær J; Jørgensen TM
Pediatr Nephrol; 2012 Nov; 27(11):2099-2106. PubMed ID: 22710694
[TBL] [Abstract][Full Text] [Related]
30. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
[TBL] [Abstract][Full Text] [Related]
31. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine.
Buelow MW; Dall A; Regner K; Weinberg C; Bartz PJ; Sowinski J; Rudd N; Katzmark L; Tweddell JS; Earing MG
Congenit Heart Dis; 2012; 7(5):441-7. PubMed ID: 22537138
[TBL] [Abstract][Full Text] [Related]
32. [Investigation on individualized adjustment of target range of high-dose methotrexate].
Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation.
Malyszko J; Malyszko JS; Koc-Zorawska E; Kozminski P; Mysliwiec M
Kidney Blood Press Res; 2009; 32(6):464-9. PubMed ID: 20068352
[TBL] [Abstract][Full Text] [Related]
34. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.
Nathan PC; Maze R; Spiegler B; Greenberg ML; Weitzman S; Hitzler JK
Pediatr Blood Cancer; 2004 Jan; 42(1):24-9. PubMed ID: 14752790
[TBL] [Abstract][Full Text] [Related]
35. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
[TBL] [Abstract][Full Text] [Related]
36. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S
Kidney Blood Press Res; 2007; 30(6):408-15. PubMed ID: 17901710
[TBL] [Abstract][Full Text] [Related]
37. Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels.
Lin HY; Lee SC; Lin SF; Hsiao HH; Liu YC; Yang WC; Hwang DY; Hung CC; Chen HC; Guh JY
Kaohsiung J Med Sci; 2013 Jun; 29(6):304-11. PubMed ID: 23684135
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
39. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation.
Szewczyk M; Wielkoszyński T; Zakliczyński M; Zembala M
Transplant Proc; 2009 Oct; 41(8):3242-3. PubMed ID: 19857721
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma.
Nakano T; Kobayashi R; Matsushima S; Hori D; Yanagi M; Suzuki D; Kobayashi K
Int J Hematol; 2021 May; 113(5):744-750. PubMed ID: 33389654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
